Holen Sie sich die Stockscreener-App
4.01
0.99%
-0.04
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
20.23%
2.169
|
1.804 | 1.222 | - | 1.141 |
Operating Expenses
|
10.37%
9.872
|
11.01 | 13.34 | 16.92 | 17.58 |
| Benefits Costs and Expenses |
-
|
- | 12.26 | 15.94 | - |
| Costs And Expenses |
10.37%
9.872
|
11.01 | 12.26 | 15.94 | 17.58 |
| Operating Income/Loss |
16.36%
-7.703
|
-9.21 | -12.12 | -16.92 | -16.44 |
| Nonoperating Income/Loss |
13.87%
0.559
|
0.649 | 1.075 | 0.98 | 1.267 |
| Income/Loss From Continuing Operations Before Tax |
20.23%
2.169
|
1.804 | -11.04 | -15.94 | 1.141 |
| Income/Loss From Continuing Operations After Tax |
16.55%
-7.144
|
-8.561 | -11.04 | -15.94 | -15.18 |
|
Net Income/Loss
|
16.55%
-7.144
|
-8.561 | -11.04 | -15.94 | -15.18 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.09%
1.9194
|
1.9176 | 38.34 | 0.0341 | 38.25 |
| Diluted Average Shares |
0.09%
1.9194
|
1.9176 | 38.34 | 0.0341 | 38.25 |
| Basic Earnings Per Share |
16.59%
-3.72
|
-4.46 | -0.29 | -0.41 | -0.40 |
| Diluted Earnings Per Share |
16.59%
-3.72
|
-4.46 | -0.29 | -0.41 | -0.40 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):